HER2 항체 시장 : 세계 산업 분석, 규모, 점유율, 성장, 동향 및 예측(2024-2034년)
HER2 Antibodies Market (Type of Treatment Drugs: Trastuzumab, Lapatinib, Ado-trastuzumab Emtansine, Pertuzumab, and Everolimus) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2024-2034
상품코드:1487627
리서치사:Transparency Market Research
발행일:2024년 04월
페이지 정보:영문 112 Pages
라이선스 & 가격 (부가세 별도)
한글목차
HER2 항체 시장 - 조사 범위
TMR의 조사 보고서 "세계 HER2 항체 시장"은 2024년부터 2034년까지의 예측 기간 동안 시장 지표에 대한 귀중한 통찰력을 얻기 위해 과거뿐만 아니라 현재의 성장 동향과 기회도 조사했습니다. 이 보고서는 2024년을 기준연도로, 2034년을 예측연도로 설정하여 2018년부터 2034년까지 세계 HER2 항체 시장의 수익을 제공합니다. 또한 2024년부터 2034년까지 세계 HER2 항체 시장의 복합 연간 성장률(CAGR%)도 제공합니다.
이 보고서는 1차적으로 KOL(Key Opinion Leader), 업계 리더, 오피니언 제조업체를 인터뷰하고, 2차적으로 주요 기업의 제품 자료, 연례 보고서, 보도 자료, 관련 문서를 검토하여 HER2 항체 시장을 파악하기 위해 광범위한 조사를 통해 작성되었습니다. 참고하였습니다.
시장 현황
2023년 시장 규모
90억 달러
2034년 시장 가치
157억 달러
CAGR
5.1%
이 보고서는 세계 HER2 항체 시장 경쟁 구도를 심층적으로 분석합니다. 세계 HER2 항체 시장에서 사업을 운영하는 주요 기업들이 확인되었으며, 각 기업들은 다양한 속성으로 프로파일링되었습니다. 기업 개요, 재무 상태, 최근 동향, SWOT는 세계 HER2 항체 시장의 기업들이 이 보고서에서 소개하는 속성입니다.
목차
제1장 서문
제2장 전제조건과 조사 방법
제3장 주요 요약 : 세계 시장
제4장 시장 개요
서론
시장 개요
시장 역학
세계 시장 분석과 예측, 2020-2034년
제5장 주요 인사이트
파이프라인 분석
주요 제품/브랜드 분석
주요 M&A
COVID-19 팬데믹의 산업에 대한 영향
제6장 세계 시장 분석과 예측 : 치료제 유형별
서론과 정의
주요 조사 결과/발전
시장 매출 예측 : 치료제 유형별, 2020년-2034년
Trastuzumab
Lapatinib
Ado-trastuzumab Emtansine
Pertuzumab
Everolimus
시장의 매력 분석 : 치료제 유형별
제7장 세계 시장 분석과 예측 : 지역별
주요 조사 결과
시장 매출 예측 : 지역별, 2020-2034
북미
유럽
아시아태평양
라틴아메리카
중동 및 아프리카
시장의 매력 분석 : 지역별
제8장 북미 시장 분석과 예측
제9장 유럽 시장 분석과 예측
제10장 아시아태평양 시장 분석과 예측
제11장 라틴아메리카 시장 분석과 예측
제12장 중동 및 아프리카 시장 분석과 예측
제13장 경쟁 구도
시장 경쟁 매트릭스(기업 Tier별, 기업 규모별)
시장 점유율 분석 : 기업별(2023년)
기업 개요
Novartis AG
Pfizer, Inc.
F. Hoffmann-La Roche Ltd.
Abnova Corporation
InvivoGen
Celltrion, Inc.
Biocon
Novus Biologicals
LSH
영문 목차
영문목차
HER2 Antibodies Market - Scope of Report
TMR's report on the global HER2 antibodies market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2024 to 2034. The report provides revenue of the global HER2 antibodies market for the period 2018-2034, considering 2024 as the base year and 2034 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global HER2 antibodies market from 2024 to 2034.
The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players' product literature, annual reports, press releases, and relevant documents to understand the HER2 antibodies market.
Market Snapshot
Market Value in 2023
US$ 9 Bn
Market Value in 2034
US$ 15.7 Bn
CAGR
5.1%
Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the global HER2 antibodies market.
The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report throws light on the changing competitive dynamics in the global HER2 antibodies market. These serve as valuable tools for existing market players as well as for entities interested in participating in the global HER2 antibodies market.
The report delves into the competitive landscape of the global HER2 antibodies market. Key players operating in the global HER2 antibodies market have been identified and each one of these has been profiled in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are the attributes of players in the global HER2 antibodies market profiled in this report.
Key Questions Answered in Global HER2 antibodies Market Report:
What is the sales/revenue generated by HER2 antibodies across all regions during the forecast period?
What are the opportunities in the global HER2 antibodies market?
What are the major drivers, restraints, opportunities, and threats in the market?
Which regional market is set to expand at the fastest CAGR during the forecast period?
Which segment is expected to generate the highest revenue globally in 2034?
Which segment is projected to expand at the highest CAGR during the forecast period?
What are the market positions of different companies operating in the global market?
HER2 Antibodies Market - Research Objectives and Research Approach
The comprehensive report on the global HER2 antibodies market begins with an overview, followed by the scope and objectives of the study. The report provides detailed explanation of the objectives behind this study and key vendors and distributors operating in the market and regulatory scenario for approval of products.
For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section divided into smaller ones. The report comprises an exhaustive collection of graphs and tables that are appropriately interspersed. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of the market shares of key segments in the past and at the end of the forecast period.
The report analyzes the global HER2 antibodies market in terms of product, end-user, and region. Key segments under each criterion have been studied at length, and the market share for each of these at the end of 2034 has been provided. Such valuable insights enable market stakeholders in making informed business decisions for investment in the global HER2 antibodies market.
Table of Contents
1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Global HER2 Antibodies Market
4. Market Overview
4.1. Introduction
4.1.1. Product Definition
4.1.2. Industry Evolution/Developments
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. Global HER2 Antibodies Market Analysis and Forecast, 2020-2034
5. Key Insights
5.1. Pipeline Analysis
5.2. Key Product/Brand Analysis
5.3. Key Mergers & Acquisitions
5.4. COVID-19 Pandemic Impact on Industry
6. Global HER2 Antibodies Market Analysis and Forecast, by Type of Treatment Drugs
6.1. Introduction & Definition
6.2. Key Findings/Developments
6.3. Market Value Forecast, by Type of Treatment Drugs, 2020-2034
6.3.1. Trastuzumab
6.3.2. Lapatinib
6.3.3. Ado-trastuzumab Emtansine
6.3.4. Pertuzumab
6.3.5. Everolimus
6.4. Market Attractiveness Analysis, by Type of Treatment Drugs
7. Global HER2 Antibodies Market Analysis and Forecast, by Region
7.1. Key Findings
7.2. Market Value Forecast, by Region, 2020-2034
7.2.1. North America
7.2.2. Europe
7.2.3. Asia Pacific
7.2.4. Latin America
7.2.5. Middle East & Africa
7.3. Market Attractiveness Analysis, by Region
8. North America HER2 Antibodies Market Analysis and Forecast
8.1. Introduction
8.2. Key Findings
8.3. Market Value Forecast, by Type of Treatment Drugs, 2020-2034
8.3.1. Trastuzumab
8.3.2. Lapatinib
8.3.3. Ado-trastuzumab Emtansine
8.3.4. Pertuzumab
8.3.5. Everolimus
8.4. Market Value Forecast, by Country, 2020-2034
8.4.1. U.S.
8.4.2. Canada
8.5. Market Attractiveness Analysis
8.5.1. By Type of Treatment Drugs
8.5.2. By Country
9. Europe HER2 Antibodies Market Analysis and Forecast
9.1. Introduction
9.2. Key Findings
9.3. Market Value Forecast, by Type of Treatment Drugs, 2020-2034
9.3.1. Trastuzumab
9.3.2. Lapatinib
9.3.3. Ado-trastuzumab Emtansine
9.3.4. Pertuzumab
9.3.5. Everolimus
9.4. Market Value Forecast, by Country/Sub-region, 2020-2034
9.4.1. Germany
9.4.2. U.K.
9.4.3. France
9.4.4. Italy
9.4.5. Spain
9.4.6. Rest of Europe
9.5. Market Attractiveness Analysis
9.5.1. By Type of Treatment Drugs
9.5.2. By Country/Sub-region
10. Asia Pacific HER2 Antibodies Market Analysis and Forecast
10.1. Introduction
10.2. Key Findings
10.3. Market Value Forecast, by Type of Treatment Drugs, 2020-2034
10.3.1. Trastuzumab
10.3.2. Lapatinib
10.3.3. Ado-trastuzumab Emtansine
10.3.4. Pertuzumab
10.3.5. Everolimus
10.4. Market Value Forecast, by Country/Sub-region, 2020-2034
10.4.1. China
10.4.2. Japan
10.4.3. India
10.4.4. Australia & New Zealand
10.4.5. Rest of Asia Pacific
10.5. Market Attractiveness Analysis
10.5.1. By Type of Treatment Drugs
10.5.2. By Country/Sub-region
11. Latin America HER2 Antibodies Market Analysis and Forecast
11.1. Introduction
11.2. Key Findings
11.3. Market Value Forecast, by Type of Treatment Drugs, 2020-2034
11.3.1. Trastuzumab
11.3.2. Lapatinib
11.3.3. Ado-trastuzumab Emtansine
11.3.4. Pertuzumab
11.3.5. Everolimus
11.4. Market Value Forecast, by Country/Sub-region, 2020-2034
11.4.1. Brazil
11.4.2. Mexico
11.4.3. Rest of Latin America
11.5. Market Attractiveness Analysis
11.5.1. By Type of Treatment Drugs
11.5.2. By Country/Sub-region
12. Middle East & Africa HER2 Antibodies Market Analysis and Forecast
12.1. Introduction
12.2. Key Findings
12.3. Market Value Forecast, by Type of Treatment Drugs, 2020-2034
12.3.1. Trastuzumab
12.3.2. Lapatinib
12.3.3. Ado-trastuzumab Emtansine
12.3.4. Pertuzumab
12.3.5. Everolimus
12.4. Market Value Forecast, by Country/Sub-region, 2020-2034
12.4.1. GCC Countries
12.4.2. South Africa
12.4.3. Rest of Middle East & Africa
12.5. Market Attractiveness Analysis
12.5.1. By Type of Treatment Drugs
12.5.2. By Country/Sub-region
13. Competition Landscape
13.1. Market Player - Competitive Matrix (by Tier and Size of Companies)
